Compared to COVID-19 patients without DM, the levels of C-reactive protein (CRP), myoglobin, alanine transaminase (ALT), and aspartate aminotransferase (AST) were significantly increased in DM patients (Table 1). This evidence concerns the gene MB and diabetes mellitus.